Skip to McMaster Navigation Skip to Site Navigation Skip to main content
McMaster Logo McMaster logo

Secukinumab treatment in rheumatoid arthritis is associated with incremental benefit in the clinical outcomes and HRQoL improvements that exceed minimally important thresholds

Authors:
Strand, V.; Kosinski, M.; Gnanasakthy, A.; Mallya, U.; Mpofu, S.
Journal:
Health & Quality of Life Outcomes
Year:
2014
DOI